Anonymous20 days ago
Major U.S. cardiology organizations released landmark 2026 guidelines recommending that adults as young as 30 assess their cholesterol risk and consider statin therapy when LDL cholesterol reaches 160 mg/dL or higher — lowering the screening age from 40 and introducing 30-year risk projections via the new PREVENT calculator. The guidelines also establish tiered LDL targets, recommend universal lipoprotein(a) testing, and strengthen coronary artery calcium scanning recommendations, while sparking debate about the balance between early intervention and potential overtreatment of younger, healthy adults.